113 related articles for article (PubMed ID: 6945832)
21. An evaluation of two methods for detection of circulating immune complexes in patients with rheumatoid arthritis.
Sølling J; Sølling K; Lassen L
Scand J Rheumatol; 1980; 9(2):118-22. PubMed ID: 7001616
[TBL] [Abstract][Full Text] [Related]
22. Decline of circulating immune complexes in rheumatoid arthritis: patients treated with tiopronine.
Bendaoud B; Delecoeuillerie G; Katsikis P; Le Goff P; Youinou P
Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):291-5. PubMed ID: 2640050
[TBL] [Abstract][Full Text] [Related]
23. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.
Scott DG; Bacon PA; Allen C; Elson CJ; Wallington T
Clin Exp Immunol; 1981 Jan; 43(1):54-63. PubMed ID: 7249394
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of autologous and homologous IgG in rheumatoid arthritis.
Catalano MA; Krick EH; De Heer DH; Nakamura RM; Theofilopoulos AN; Vaughan JH
J Clin Invest; 1977 Aug; 60(2):313-22. PubMed ID: 874093
[TBL] [Abstract][Full Text] [Related]
25. [Enzyme therapy in comparison with immune complex determinations in chronic polyarthritis].
Steffen C; Smolen J; Miehlke K; Hörger I; Menzel J
Z Rheumatol; 1985; 44(2):51-6. PubMed ID: 4050140
[TBL] [Abstract][Full Text] [Related]
26. Complement activation and immune complexes in juvenile rheumatoid arthritis.
Jarvis JN; Pousak T; Krenz M; Iobidze M; Taylor H
J Rheumatol; 1993 Jan; 20(1):114-7. PubMed ID: 8441140
[TBL] [Abstract][Full Text] [Related]
27. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
28. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.
Mallya RK; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
J Rheumatol; 1982; 9(2):224-8. PubMed ID: 7097681
[TBL] [Abstract][Full Text] [Related]
29. Immune complexes in early arthritis. II. Immune complex constituents are synthesized in the synovium before rheumatoid factors.
Jones VE; Jacoby RK; Cowley PJ; Warren C
Clin Exp Immunol; 1982 Jul; 49(1):31-40. PubMed ID: 7127902
[TBL] [Abstract][Full Text] [Related]
30. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
Emlen W; Niebur J; Flanders G; Rutledge J
J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
[TBL] [Abstract][Full Text] [Related]
31. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?
Mäkinen H; Kautiainen H; Hannonen P; Sokka T
Ann Rheum Dis; 2005 Oct; 64(10):1410-3. PubMed ID: 15941836
[TBL] [Abstract][Full Text] [Related]
32. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
34. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years.
Flatø B; Lien G; Smerdel A; Vinje O; Dale K; Johnston V; Sørskaar D; Moum T; Ploski R; Førre Ø
J Rheumatol; 2003 Feb; 30(2):386-93. PubMed ID: 12563700
[TBL] [Abstract][Full Text] [Related]
36. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
37. Migration of blood and synovial fluid neutrophils obtained from patients with rheumatoid arthritis.
Kemp AS; Brown S; Brooks PM; Neoh SH
Clin Exp Immunol; 1980 Jan; 39(1):240-6. PubMed ID: 7389195
[TBL] [Abstract][Full Text] [Related]
38. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
39. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis.
Al-Matar MJ; Petty RE; Tucker LB; Malleson PN; Schroeder ML; Cabral DA
Arthritis Rheum; 2002 Oct; 46(10):2708-15. PubMed ID: 12384930
[TBL] [Abstract][Full Text] [Related]
40. [Circulating immune complexes and clinical manifestations of rheumatoid arthritis].
Meyer O; Halkidou-Karaberi H; Ryckewaert A
Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):289-90. PubMed ID: 4001819
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
